Yilin Xu

Oct 9, 2024 | nature.com | Naiara Perurena |Yoona Yang |Carrie Rodriguez |Alycia Gardner |Patrick Loi |Yilin Xu | +9 more

AbstractTriple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and has the highest rate of recurrence1. The predominant standard of care for advanced TNBC is systemic chemotherapy with or without immunotherapy; however, responses are typically short lived1,2. Thus, there is an urgent need to develop more effective treatments. Components of the PI3K pathway represent plausible therapeutic targets; more than 70% of TNBCs have alterations in PIK3CA, AKT1 or PTEN3,4,5,6.

Jun 22, 2024 | mdpi.com | Joseph Leung |Allison Loan |Yilin Xu |Guang Yang

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Oct 6, 2023 | universal-robots.com | Yilin Xu

WorkforceProductivityInnovationFor a decade, China has been the world’s largest industrial robot market and in 2022 the country accounted for half of all global robot installations. But despite being the world’s foremost user of robotics, China isn’t complacent.

Sep 20, 2023 | dovepress.com | Cheng Peng |Yilin Xu |Jing Wu |Donghai Wu

Back to Journals » International Journal of Nanomedicine » Volume 19 Authors Peng C , Xu Y, Wu J, Wu D, Zhou L, Xia X Received 20 September 2023 Accepted for publication 21 December 2023 Published 4 January 2024 Volume 2024:19 Pages 109—135 DOI https://doi.org/10.2147/IJN.S441135 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Professor Jie Huang Cheng Peng, Yilin Xu, Jing Wu, Donghai Wu, Lili Zhou, Xinhua Xia School...